Tag: clinical study

AR101

Results of Phase III Trial of Aimmune’s Peanut OIT Therapy

After one year, 3/4 of patients ages 4-17 who received the therapy were able to consume a minimum of 300mg of peanut. Results for adults were less clear.
Microbiome

Study: Diagnosing Food Allergy via Fecal Sample

The study could lead to new diagnostics that may obviate the need for food challenges.
AR101

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

The company announces their timeline for continued progress toward an FDA approved standardized therapy.
Xolair (omalizumab)

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.
Nasal Spray

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Could lead the way to approval of a less anxiety provoking method of epinephrine administration.
Patient with Doctor

Study: The Effect of OIT in Severe Milk, Peanut and Egg...

Rest assured, there *is* research being done to determine how immunotherapies can benefit adults.
DBV Patch Closeup

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.
Kanagawa Children's Medical Center

Study: Nine Children Suffer Severe Symptoms in OIT Trial

The survey was initiated after a report that a child suffered cardio-respiratory arrest during OIT.
DNA

Genome Study Provides More Clarity on Genetic Causes of Food Allergy

Study provides more clues in the race to understand the causes and develop treatments for food allergies.
Peanut Therapy

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.

Connect with Us

30,186FansLike
90FollowersFollow
4,591FollowersFollow
35SubscribersSubscribe